Not just “one of those things”

Arri Coomarasamy, Professor of Gynaecology & Reproductive Medicine at the University of Birmingham and Director of Tommy’s National Centre for Miscarriage Research, discusses why urgent changes should be made to NHS policy and how appropriate care should be provided to all women who have experienced one or more miscarriages. In my clinic when I see … Continue reading “Not just “one of those things””

Birmingham spinout lands funding for rapid development of fluorescent dyes

ChromaTwist Ltd, a spinout of BHP founder-member the University of Birmingham, has secured £300k of seed funding to develop a new class of fluorescent materials for use in bio-sensing and bio-imaging diagnostic tests for diseases such as cancer and diabetes. The funding round includes £250k private equity investment from angels and a £50k investment from … Continue reading “Birmingham spinout lands funding for rapid development of fluorescent dyes”

Weight loss surgery significantly reduces brain pressure in patients with IIH

Weight loss surgery is more effective than dieting to reduce brain pressure that can cause blindness in patients with a neurological condition, finds a study led by Birmingham Health Partners founder-members the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust (UHB). Idiopathic Intracranial Hypertension (IIH) is a debilitating condition that raises pressure in the … Continue reading “Weight loss surgery significantly reduces brain pressure in patients with IIH”

End the postcode lottery in miscarriage care and treatment, say researchers

Leading experts at BHP founder-member the University of Birmingham and Tommy’s National Centre for Miscarriage Research are calling on the UK government to invest in early pregnancy units and recurrent miscarriage clinics to end the current care and treatment postcode lottery. The calls come as the team has laid bare the devastating impact of miscarriage … Continue reading “End the postcode lottery in miscarriage care and treatment, say researchers”

Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine

New research carried out in collaboration with researchers from Birmingham Health Partners has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots. The research has identified fundamental laboratory and clinical characteristics, ensuring that patients are given the correct treatment approach. Published in the New England Journal of Medicine, the research describes rare cases of blood … Continue reading “Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine”